 VI. To identify biomarkers of response to chemotherapy by fludeoxyglucose F 18 FDG-positron emission tomography PETcomputed tomography CT imaging that are predictive of histopathologic remissions and survival in patients with stage I mediastinal, II, III, or IV untreated DLBCL. 